Agomab receives US patent for lung fibrosis drug candidate AGMB-447 Mar 26, 2026 07:01AM
Leerink Partners Starts Agomab Therapeutics (AGMB) at Outperform Mar 3, 2026 06:32AM
Morgan Stanley Starts Agomab Therapeutics (AGMB) at Overweight Mar 3, 2026 04:26AM
JPMorgan Starts Agomab Therapeutics (AGMB) at Overweight Mar 3, 2026 02:08AM
Agomab (AGMB) files for 12.5M share Nasdaq IPO at $15-$17/sh Jan 29, 2026 07:34AM


Jan 16, 2026 04:26PM Agomab (AGMB) files for proposed IPO